Oxford Biomedica (UK) Limited

Where the EU money came from

Funding by EU programme. Amounts are Oxford Biomedica (UK) Limited's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• IMPROVEPartner

  Improving Prostate Cancer Outcome with Vectored Vaccines

  FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗

  €184ktheir share
• NEUGENEPartner

  Advanced gene therapy tools for treatment of CNS-specific disorders

  FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

  €100ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Commissariat A L Energie Atomique et aux Energies AlternativesFrance · 1 shared project
• The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 1 shared project
• Ecole Polytechnique Federale de LausanneSwitzerland · 1 shared project
• Universite de LausanneSwitzerland · 1 shared project
• MAX IV Laboratory, Lund UniversitySweden · 1 shared project
• Universitaetsmedizin Goettingen - Georg-August-Universitaet Goettingen - Stiftung Oeffentlichen RechtsGermany · 1 shared project
• Royal Holloway and Bedford New CollegeUnited Kingdom · 1 shared project
• Glaxosmithkline Vaccines SRLItaly · 1 shared project
• Astrazeneca Computational Pathology GmbHGermany · 1 shared project
• Externautics SpAItaly · 1 shared project
• Vaccitech LtdUnited Kingdom · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• gene therapy
• parkinson
• pathophysiology
• prostate cancer
• virology